30 plain text records from this source:
https://huggingface.co/datasets/starmpcc/Asclepius-Synthetic-Clinical-Notes/viewer/default/train?row=0

1	
Discharge Summary: Admission Date: [Insert Date] Discharge Date: [Insert Date] Patient Name: [Insert Name] Age/Sex: 39-year-old Male Medical Record Number: [Insert Number] Admission Diagnosis: Unspecified respiratory tract infection Discharge Diagnosis: Resolved respiratory tract infection Hospital Course: The patient was hospitalized due to persistent fever and dry cough for 2 weeks, leading to reduced general health condition. On admission, the patient required 4 L/min of oxygen due to rapid shallow breathing at rest and severe breathlessness during minor physical activity. The initial physical therapy focused on educating the patient on dyspnea-relieving positions, mobilization techniques, and deep-breathing exercises. However, with time, the patient's anxiety-induced dyspnea became an issue, leading to the modification of therapy to relieve his dyspnea. The patient positively responded to the therapy, evidenced by a reduction in respiratory rate from 30 to 22 breaths/min and an increase in oxygen saturation from 92% to 96% on 4 L/min oxygen. Over the next few days, his dyspnea and anxiety started to alleviate gradually, and the patient regained his self-confidence. The therapy was eventually shifted to walking and strength training, and the patient was able to walk for 350m without a walking aid or supplemental oxygen before discharge. Hospital Outcome: The patient was discharged home in an improved condition, with resolved respiratory tract infection, showing no need for further hospitalization. The patient was advised to follow-up with his regular healthcare professional for further monitoring and management of his health status. Discharge Medications: None Follow-up: The patient was advised to follow-up with his regular healthcare professional regarding further monitoring and management of his health status. Impression: Resolved respiratory tract infection with successful physical therapy for dyspnea relief and anxiety reduction. The patient responded well to therapy and regained his self-confidence, able to walk independently before discharge.	
Which coreferences were resolved in the hospital course section related to the patient's respiratory tract infection?	
The hospital course section resolved the coreferences related to the patient's respiratory tract infection by providing information on the initial physical therapy, which focused on dyspnea-relieving positions, mobilization techniques, and deep-breathing exercises, and the modified therapy that targeted the patient's anxiety-induced dyspnea. The patient positively responded to the therapy, alleviating his dyspnea and anxiety, and was eventually able to walk independently before discharge, indicating that his respiratory tract infection had been resolved.	
Coreference Resolution
2	
Hospital Course Summary: Admission Date: [Insert date] Discharge Date: [Insert date] Patient: [Patient's Name] Sex: Male Age: 57 years Admission Diagnosis: Oxygen Desaturation Hospital Course: The patient was admitted to the ICU one week after a positive COVID-19 result due to oxygen desaturation. Physical therapy was initiated promptly after admission, which helped improve the patient's breathing frequency and oxygen saturation. The patient was guided to achieve a prone position resulting in a significant increase in oxygen saturation from 88% to 96%. The patient continued to receive intensive physical therapy, positioning, and oxygen therapy for the next few days. Although there were challenges in achieving the prone position due to the patient's profoundly reduced respiratory capacity and high risk of symptom exacerbation, the medical team succeeded in implementing a safe and individualized approach. After three days with this regime, the patient was transferred to the normal ward, where physical therapists continued his rehabilitation, including walking and strength training. However, the patient's severe instability remained a challenge. Nevertheless, after nine days from ICU admission, the patient was successfully discharged from the hospital as a pedestrian. Discharge Condition: At the time of discharge, the patient's medical condition had significantly improved, and he was considered stable enough to be discharged from the hospital. The patient's oxygen saturation had returned to normal limits, and his breathing frequency had decreased significantly. Summary: This course summary demonstrates that the patient responded positively to a physical therapy treatment regimen, including positioning, deep-breathing exercises, and walking. Although the patient's medical condition was quite severe during the initial ICU admission, his rehabilitation resulted in marked improvement, leading to a successful discharge from the hospital.	
What were the key improvements in the patient's medical condition during the hospital course, and how was physical therapy utilized to achieve these results?	
During the hospital course, the patient's medical condition improved significantly, with his breathing frequency decreasing and oxygen saturation returning to normal limits. Physical therapy was utilized with a regimen that included positioning, deep-breathing exercises, and walking. The patient was guided to achieve a prone position resulting in a significant increase in oxygen saturation from 88% to 96%. The physical therapists also continued rehabilitation, including walking and strength training.	
Summarization
3	
Discharge Summary: Patient: 69-year-old male Hospital Course: The patient was admitted to the ICU due to COVID-19 pneumonia, which was diagnosed after he experienced a dry cough for 2 weeks and showed poor oxygenation. Initially, he was given lung-protective ventilation and targeted sedation, and he remained stable. However, his condition worsened over the next days, and he developed hemodynamic instability and severe Acute Respiratory Distress Syndrome (ARDS). The patient underwent intermittent prone positioning and continuous renal replacement therapy because of these complications. Physical therapists were involved in this process, and they were responsible for ensuring the correct positioning of the patient's joints and preventing secondary complications, such as pressure ulcers, nerve lesions and contractures. After the tracheostomy, the patient underwent passive range-of-motion exercises and passive side-edge mobilization. However, asynchronous ventilation and hemodynamic instability persisted, inhibiting active participation. After spending 24 days in the ICU, the patient showed severe signs of muscle loss and scored 1/50 points on the Chelsea Critical Care Physical Assessment Tool (CPAx). The patient died soon after the withdrawal of life support. Hospital Stay: The patient was in the ICU for 24 days, where he received treatment interventions, including passive range of motion and positioning, intermittent prone positioning, and continuous renal replacement therapy. While in the ICU, the patient showed severe signs of muscle loss and developed pressure ulcer on the forehead. Discharge Instruction: The patient has been discharged in a stable condition. Although the patient was not discharged, we offer our sincere condolences to his family.	
What roles did physical therapists have in the patient's treatment, and what secondary complications did they work to prevent? (Related to the task of relation extraction)	
Physical therapists were responsible for ensuring the correct positioning of the patient's joints and preventing secondary complications, such as pressure ulcers, nerve lesions and contractures.	
Relation Extraction
4	
Discharge Summary: Patient Information: - Name: [Redacted] - Age: 57 - Gender: Male - Admission Date: [Redacted] - Discharge Date: N/A - Medical Record Number: [Redacted] Hospital Course Summary: - The patient was admitted to the ICU with symptoms of dyspnea, heavy dry cough, and fever after testing positive for COVID-19. - Despite initial ability to exercise and sit in a chair with a physical therapist, the patient's respiratory condition progressively worsened, requiring intubation and proning. - The patient's large amounts of bronchial mucus and respiratory failure necessitated regular suctioning and respiratory therapy. - Manual airway clearance techniques were employed by 1-2 physical therapists to increase effective airway clearance while avoiding alveolar collapse with some success. - After extubation, the patient continued to require intensive manual airway clearance techniques, nasal rinsing, and airway suctioning. - Additional physical therapy interventions, including passive range of motion, assisted exercising, and mobilization, were also utilized. - At the time of writing, the patient remained in the ICU without ventilatory support. Summary of Events: - The patient presented with symptoms of COVID-19, including dyspnea, heavy dry cough, and fever. - Despite intubation and proning, the patient's respiratory condition continued to worsen, requiring regular suctioning and respiratory therapy. - Manual airway clearance techniques were used to increase expiratory flow for effective airway clearance. - After extubation, the patient continued to require intensive manual airway clearance techniques, nasal rinsing, and airway suctioning. - The patient also received additional physical therapy interventions to aid in recovery. - At the time of writing, the patient remained in the ICU without ventilatory support. Impression: - The patient presented with symptoms of COVID-19 and suffered from respiratory failure necessitating intubation, proning, manual airway clearance techniques, and extensive respiratory therapy. - Despite initial improvements, the patient continues to require intensive manual airway clearance techniques, nasal rinsing, airway suctioning, and additional physical therapy. - The patient has not yet been discharged.	
What manual airway clearance techniques were utilized to aid in the recovery of the COVID-19 patient suffering from respiratory failure? (related to the task of Relation Extraction)	
The discharge summary stated that 1-2 physical therapists utilized manual airway clearance techniques to increase effective airway clearance while avoiding alveolar collapse with some success, but did not specify what particular manual airway clearance techniques were utilized.	
Relation Extraction
5	
Discharge Summary: Patient: 52-year-old male hospitalized for pneumonia and moderate ARDS Hospital Course: The patient was admitted to the hospital four days after the beginning of a dry cough, fever, and head and limb pain and tested COVID-19 positive. One day later, he was diagnosed with pneumonia that progressed into moderate ARDS and required mechanical ventilation and intermittent dialysis. After extubation, the patient experienced disorientation and an inability to communicate verbally due to global weakness (CPAx 11/50), accompanied by oral and pharyngeal weakness and paresthesia. Specialized physical therapy with the Gugging Swallowing Screen confirmed severe dysphagia, with the patient showing insufficient protection against aspiration. Treatment included therapy for dysphagia, such as intensive oral stimulation, facilitation of swallowing, and protection mechanism training, while receiving no food or drink by mouth. Over the next few days, the patient was able to swallow pureéd food and mildly thick liquids under supervision, although cough strength remained weak. The patient progressed gradually and became capable of independent food ingestion before discharge. Discharge: The patient was discharged 25 days after admission to a rehabilitation clinic. The patient's respiratory condition stabilized, although dysphagia was still evident, with mild oral and pharyngeal dry saliva residuals that continued to compromise paresthesia and needed ongoing regular oral care. Overall, the patient's condition improved and continued to progress during the hospital stay.	
How did the patient's treatment for dysphagia progress during their hospital stay, as outlined in the discharge summary?	
During the patient's hospital stay, treatment for dysphagia progressed gradually, including intensive oral stimulation, facilitation of swallowing, and protection mechanism training. After being unable to eat or drink orally, the patient progressed to pureéd food and mildly thick liquids under supervision, with cough strength remaining weak. The patient eventually became capable of independent food ingestion before discharge.	
Summarization
6	
DISCHARGE SUMMARY: Patient Name: N/A Date of Discharge: N/A Admitting Physician: N/A Attending Physician: N/A Date of Admission: N/A Date of Discharge: N/A HOSPITAL COURSE: This 59-year-old female presented with dyspnea and an oxygen saturation level of 65%, leading to an immediate tracheal intubation due to moderate acute respiratory distress syndrome (ARDS) with reduced lung compliance. After being diagnosed, the patient was treated with deep sedation, neuromuscular blocking agents, and prone positioning. On day 14, a trial of sitting on the edge-of-bed (SOEB) was performed, resulting in a significant increase in the patient's level of consciousness and collaborative state. The patient's muscle strength indicated ICU-acquired weakness, with a Medical Research Council sum-score (MRC-SS) of 40/60. Despite the weakness, she was continuously encouraged to mobilize herself with exercises against gravity, and she was actively transferred to a chair each day. After successful extubation, she presented postextubation dysphagia, which was closely monitored for secretion management and cough stimulation. Physical rehabilitation was continued, and the patient started walking with a walking aid on day 19. Her oxygen desaturation during exercise training became evident at this point, and after 25 days, she was transferred to the institution's rehabilitation facilities where she received further treatment. DISCHARGE DIAGNOSES: - Moderate acute respiratory distress syndrome (ARDS) with reduced lung compliance - Postextubation dysphagia - ICU-acquired weakness - Persistent physical function impairment PROCEDURES: - Immediate tracheal intubation - Sitting on the edge-of-bed (SOEB) trial - Continuous physical therapy - Successful extubation - Close monitoring for secretion management and cough stimulation - Walking with a walking aid SUMMARY OF CARE: This document serves as a summary of the hospital course of a 59-year-old female admitted due to dyspnea and diagnosed with moderate acute respiratory distress syndrome (ARDS) with reduced lung compliance. After treatment, a trial of sitting on the edge-of-bed (SOEB) was performed, resulting in the patient's significant level of consciousness improvement. Despite experiencing ICU-acquired weakness, the patient was continuously encouraged to mobilize herself with exercises against gravity, and after successful extubation, physical rehabilitation was continued until she was able to walk with a walking aid. The patient was transferred to the institution's rehabilitation facilities, where further treatment was administered to address her persistent physical function impairment.	
What interventions were used to treat the patient's post-extubation dysphagia and how was it managed?	
The discharge summary states that the patient's postextubation dysphagia was closely monitored for secretion management and cough stimulation, but it does not provide specific interventions that were used to treat it. Therefore, the information available in the discharge summary is unanswerable to the healthcare professional's instruction.	
Temporal Information Extraction
7	
Hospital Course: This 33-year-old female patient was admitted to the ICU due to severe COVID-19 symptoms, including high fever, dry cough, headache, and dyspnea. She was intubated and proned due to rapid respiratory deterioration and received physical therapy consisting of prone positioning and secondary damage prevention. From day 7 onwards, she exhibited significant improvement and was mobilized passively into a side-edge position. The patient was extubated but developed postextubation dysphagia and severe ICU-acquired weakness (mild muscle impairment). Post-Discharge Course: Following her discharge from the ICU, the patient continued to suffer from pronounced delirium and anxiety. She was visited by her husband, which seemed to give her a short sense of security and eased her rehabilitation. However, the delirium persisted and did not resolve upon her transfer to a peripheral acute hospital. Discharge Diagnosis: The patient exhibited severe COVID-19 symptoms followed by postextubation dysphagia and severe ICU-acquired weakness with pronounced delirium and anxiety. Discharge Condition: The patient's condition has stabilized and she was discharged to a peripheral acute hospital for further treatment. Discharge Medications: None specified. Follow-up: The patient is to follow up with her healthcare provider and/or return to the hospital for further treatment as needed.	
What was the patient's condition upon discharge from the ICU and where was she transferred to?	
The patient's condition stabilized upon discharge from the ICU. She was transferred to a peripheral acute hospital for further treatment due to persistent delirium and anxiety. No specific medications were prescribed upon discharge. The patient is advised to follow up with her healthcare provider and/or return to the hospital for further treatment as necessary.	
Relation Extraction
8	
Hospital Course: This 66-year-old male patient was admitted due to an ischemic left-hemispheric stroke in addition to a dry cough and fever. The patient tested positive for SARS-CoV-2 and experienced severe ARDS, resulting in intubation and ICU admission. The patient underwent veno-venous extracorporeal membrane oxygenation and physical therapy was initiated to focus on perception training, movement exercises, airway-clearing techniques, dysphagia therapy, and mobilization. Despite a trial of sedation cessation, the patient remained somnolent and unable to communicate or follow commands. A side-edge positioning was initiated in combination with intensive exercise training including trunk and head control. Muscle tone and strength remained severely reduced, particularly on his hemiplegic side, and a second SOEB trial failed. Occupational therapy was involved to support functional initiation of upper limb movements and to integrate perception-training into activities of daily living. Currently, the patient remains functionally dependent, tolerates spontaneous breathing trials, and is alert during therapy, although he cannot communicate. He is considered stable and functionally dependent (CPAx 6/50).	
What are the abbreviated terms in the given discharge summary that require expansion?	
The abbreviated terms that require expansion in the given discharge summary are SARS-CoV-2, ARDS, ICU, SOEB, and CPAx. SARS-CoV-2 refers to the virus that causes COVID-19. ARDS stands for acute respiratory distress syndrome. ICU stands for intensive care unit. SOEB means spontaneous awakening trial-extubation, and CPAx stands for cognitive performance assessment.	
Abbreviation Expansion
9	
Hospital Course Summary: This is a summary of the hospital course of a 66-year-old male patient who presented with fever, dyspnea, coughing, asthenia, lack of appetite, nausea, and vomiting. Upon admission, the patient received oxygen therapy and was closely observed due to moderate ARDS, which resulted in an increasing oxygen requirement. The patient was treated with deep sedation, neuromuscular blocking agents, and proning for the first 12 days of his hospital stay. Due to persisting difficult weaning status correlated to respiratory muscle weakness, tracheostomy was performed. After the tracheostomy, the patient showed improvement in his physical functions, including active SOEB, chair transfer, and active in-bed cycling against resistance for 20 minutes. The patient continued to receive pressure support during exercises, enabling unloading of respiratory muscles, which culminated in a rapid improvement in his physical function. Upon transfer to the step-down unit, the patient experienced fatigue, inspiratory muscle weakness, and dysphagia. However, his physical function ICU test score and walking distance both improved considerably. The patient remains in the hospital under observation.	
What abbreviations were used in this discharge summary related to the patient's physical function, and what are their expanded forms?	
The abbreviations used in the discharge summary related to the patient's physical function are SOEB (Self-Obtained Exercise Bike) and ICU (Intensive Care Unit), which stand for active in-bed cycling against resistance for 20 minutes and physical function ICU test score, respectively.	
Abbreviation Expansion
11	
Discharge Summary: Patient Name: [REDACTED] Medical Record Number: [REDACTED] Gender: Female Age: 45 years Hospital Course: The patient was admitted to the hospital after collapsing at home due to a hypoglycemic event. She had a history of restrictive AN, binge-purge behaviour, and an old traumatic brain injury, leaving her with memory problems. On admission, she was malnourished, cachexic, and dehydrated. Her chest X-ray showed patchy consolidations in the right middle and lower lobes. She was diagnosed with cholecystitis based on worsening liver enzymes and an abdominal ultrasound showing multiple small calculi and biliary debris, with gallbladder oedema. Treatment: The patient was treated with appropriate antibiotics and underwent an inpatient magnetic resonance cholangiopancreatography (MRCP) to rule out intra-biliary pathology, which was negative. Amoxicillin, clavulanic acid, and clarithromycin were prescribed, which resulted in improvement in her inflammatory markers. She was referred to surgeons for consideration of elective laparoscopic cholecystectomy once deemed fit. Outcome: The patient had a long and difficult admission, leading to a transfer to an Eating Disorders Unit, which was delayed due to the coronavirus disease 2019 pandemic. Her weight improved with nasogastric feeding and supplements during her hospital stay. Her liver enzymes showed improvement during the course of her treatment. She was finally discharged in stable condition to the Eating Disorders Unit, weighing 56.4 kg (BMI = 18.1) from her admission weight of 37.3 kg (BMI = 12.6). Post-Discharge Plan: The patient will continue her treatment for AN at the Eating Disorders Unit. She will be followed up regularly by the team for her medical, nutritional, and psychiatric needs. Close monitoring of her weight, liver function tests, and gallbladder status will be carried out. The patient will be advised to maintain a healthy diet and continue medications as per her discharge medications plan. Further evaluation of her cognitive and memory problems will be arranged. She will be advised to follow strict COVID-19 protocols to prevent infection. Signed, [REDACTED] MD, Hospitalist	
Can you provide a summary of the treatment, hospital course, and post-discharge plan for a 45-year-old female patient with a history of restrictive AN, binge-purge behavior, old traumatic brain injury, and cholecystitis, according to the provided discharge summary?	
The 45-year-old female patient with a history of restrictive AN, binge-purge behavior, old traumatic brain injury, and cholecystitis was treated with appropriate antibiotics, underwent an inpatient MRCP, and was referred to surgeons for elective laparoscopic cholecystectomy once deemed fit. She was finally discharged in stable condition to an Eating Disorders Unit for continuation of her treatment for AN. Close monitoring of her weight, liver function tests, and gallbladder status will be carried out, and she will be advised to follow strict COVID-19 protocols to prevent infection. However, further evaluation of her cognitive and memory problems will need to be arranged outside of the given information.	
Summarization
12	
Hospital Course Summary: Admission Date: [Date] Discharge Date: [Date] Length of Stay: 24 days Admitting Diagnosis: Severe malnutrition Hospital Course: The patient was admitted with bradycardia and hypoglycaemia with a capillary blood glucose level of 2.3 mmol/L. He had a history of eating and anxiety disorders and was severely malnourished. His blood pressure was initially un-recordable but subsequently was recorded to be 104/72 mmHg, and his capillary blood glucose level improved to 4.7 mmol/L. He was noted to be cachexic and had abnormal liver function tests. His condition improved over the course of his 24-day admission, but he had a number of hypoglycaemic events and difficulty complying with treatment. Due to problems keeping him compliant with medication and intravenous glucose, he was placed under Mental Health Act 5(2) and was started on nasogastric feeding. His liver synthetic function improved over the course of his stay, but there were some concerns about nasogastric feeding, which led to worsening LFTs. He was discharged to an Eating Disorders Unit. Discharge Diagnosis: Severe malnutrition, cachexia Disposition: Discharged to an Eating Disorders Unit Follow-up Plan: The patient was provided with a referral to the Eating Disorders Unit for continued care and management of his severe malnutrition and cachexia. Course of Treatment: - The patient was initially treated with intravenous glucose to address hypoglycaemia and rehydrate. He was subsequently started on nasogastric feeding to address his severe malnutrition and undernourishment. - His liver function tests worsened with the introduction of nasogastric feeding, but a non-invasive liver screen and ultrasound provided reassurance. - The patient's condition, LFTs, and liver synthetic function improved over the course of his admission. - The patient's compliance with treatment was challenging, and he required Mental Health Act 5(2) to ensure his continued care and management. - The patient was discharged to an Eating Disorders Unit for further care and management of his severe malnutrition and cachexia. Discharge Medications: None	
What was the patient's length of stay and course of treatment during their hospital admission for severe malnutrition and cachexia?	
The patient's length of stay was 24 days, and their course of treatment involved initial treatment with intravenous glucose, followed by nasogastric feeding to address severe malnutrition and undernourishment. Mental Health Act 5(2) was required to ensure the patient's compliance with treatment, and non-invasive liver screen and ultrasound were performed to address concerns about nasogastric feeding which led to some worsening LFTs. The patient's liver function tests and liver synthetic function improved over the course of their admission. They were discharged to an Eating Disorders Unit for further care and management.	
Temporal Information Extraction
13	
DISCHARGE SUMMARY: Patient Name: X Medical Record Number: X Date of Admission: XX/XX/XX Date of Discharge: XX/XX/XX Hospital Course: A 36-year-old premenopausal woman with a family history of colorectal, hepatobiliary cancerspresented with an abnormal right breast lump. Diagnostic mammogram and ultrasound showed a highly suggestive malignant breast mass, which was confirmed by a biopsy of the dominant lesion. The patient underwent a right breast simple mastectomy with axillary lymph node evaluation and her pathology showed a multifocal invasive mammary carcinoma with ductal and lobular features. She received adjuvant PMRT 5000 cGy dose, 25 fractions with 1000 cGy scar boost. Based on TEXT/SOFT data, ovarian suppression was recommended to be considered as the patient had high-risk features. The patient was started on ovarian suppression with goserelin 3.6 mg every 28 days along with letrozole 2.5 mg once daily. Sixteen months after initiation of ovarian suppression, the patient started having a regular menstrual cycle while on goserelin. Given the high-risk disease, the benefit of continued ovarian suppression plus AIs versus tamoxifen alone was discussed, and the patient was hesitant about oophorectomy. She was started on triptorelin 3.75 mg IM once every 28 days. Summary of Findings: The patient is a premenopausal woman with a family history of cancers who was diagnosed with a highly suggestive malignant breast mass. She underwent a right breast simple mastectomy with axillary lymph node evaluation, and the pathology revealed a multifocal invasive mammary carcinoma with ductal and lobular features. The patient received adjuvant PMRT and underwent ovarian suppression after initiation of which the patient started having a regular menstrual cycle. Triptorelin was started in place of goserelin due to failure of ovarian ablation. Current Status: The patient is now in a stable condition and was discharged with instructions to follow up with her oncologist for further management as advised. Recommended for molecular and genetic testing if not done in their initial evaluation. Also, advised to discuss the role of oophorectomy to manage risks and benefits of such treatment further with oncologist. Discharge Medications: None Follow-up Appointments: Follow up with the oncologist for further evaluation.	
Based on the given discharge summary, can you summarize the patient's treatment plan for managing their breast cancer, including recommended medications and the rationale for switching from goserelin to triptorelin?	
The patient with a multifocal invasive mammary carcinoma with high-risk features underwent a right breast simple mastectomy with axillary lymph node evaluation. Adjuvant PMRT was given, and ovarian suppression was started with goserelin 3.6 mg every 28 days along with letrozole 2.5 mg once daily. However, despite goserelin treatment, the patient started having regular menstrual cycles, and triptorelin 3.75 mg IM once every 28 days was started in place of goserelin due to failure of ovarian ablation. Follow up with the oncologist for further evaluation was recommended, along with discussion of the role of oophorectomy to manage risks and benefits of such treatment. Medications were no longer given upon discharge.	
Summarization
14	
Discharge Summary: Patient Name: N/A Gender: Male Age: 62 Date of Admission: N/A Date of Discharge: N/A Hospital Course: The patient was admitted to the hospital for elective left and right heart catheterization as a pre-transplant evaluation. The computed tomography (CT) scan showed an occlusive thrombus of the IVC that extended from the renal veins to the level of the cavoatrial junction. Thrombus was also observed in the portal vein, and multiple subcutaneous varicosities were found. Due to the patient’s history of advanced cirrhosis and large esophageal varices, anticoagulation was not an option. Palliative stenting of the IVC was performed to relieve the patient’s pain and improve his quality of life. Procedure: Right internal jugular (IJ) and right femoral vein accesses were obtained for the procedure. Initial attempts to cross the 100% occluded IVC with a Glidewire Advantage were unsuccessful. The IVC was successfully crossed with a 7-French Swan-Ganz catheter. A multipurpose catheter was then advanced into the right atrium, and the Swan-Ganz wire was replaced with a Glidewire Advantage. A 9 × 80 Mustang balloon and then a 22 × 70 mm Wallstent were used to perform IVC ballooning. Finally, an 18 × 60 Boston Scientific esophageal balloon was used to post-dilate the stent. Small clots floating around at the lower edge of the stent above the renal artery were successfully removed with a 7-Fr snare. Condition on Discharge: N/A Instructions at Discharge: N/A Follow-up Recommendations: N/A	
What coreferential expressions require resolution in the hospital course section related to the patient's diagnosis of an occlusive thrombus of the IVC and portal vein?	
The coreferential expressions that require resolution in the hospital course section are the location of the thrombus, which extended from the renal veins to the level of the cavoatrial junction, and the presence of thrombus in the portal vein.	
Coreference Resolution
15	
Discharge Summary: Patient: 45-year-old woman with a medical history of type II diabetes and primary hyperparathyroidism. Hospital Course: The patient was initially diagnosed with Langerhans cell histiocytosis (LCH) in 2006, which was treated with surgery, radiotherapy, and chemotherapy. In 2020, the patient complained of an increase in skin lesions and received chemotherapy as single-system LCH (SS-LCH) based on methotrexate, associated with prednisone and vinblastine, with the obtainment of stable response and limited regression of the lesions. However, the patient was lost to follow-up after two courses of chemotherapy. A year later, the patient was referred to the hematology department due to a major increase in skin lesions, with the appearance of new ones on her thigh. The diagnosis of Langerhans cell sarcoma was confirmed based on microscopic and phenotypic results. Hospital Course Summary: The patient, a 45-year-old non-smoker with a history of type II diabetes and primary hyperparathyroidism, presented with an increase in skin lesions, with the appearance of new ones on her thigh. The patient had a medical history of Langerhans cell histiocytosis (LCH) which was diagnosed in 2006 and had been treated with surgery, radiotherapy, and chemotherapy. In 2020, the patient received chemotherapy as single-system LCH (SS-LCH) based on methotrexate, associated with prednisone and vinblastine, with the obtainment of stable response and limited regression of the lesions. After two courses of chemotherapy, the patient was lost to follow-up. A year later, the patient was referred to the hematology department due to a major increase in skin lesions, with the appearance of new ones on her thigh. The diagnosis of Langerhans cell sarcoma was confirmed based on microscopic and phenotypic results. The patient did not receive any maintenance therapy and was included in the LCH protocol as single-system LCH (SS-LCH), and she received the same chemotherapy combining prednisone, high-dose of methotrexate, and vinblastine. After five cycles of chemotherapy, the evolution was favorable with significant regression of lesions in the thigh without the appearance of any new lesions. In the follow-up, the patient will continue to be monitored for any signs of recurrence or progression of the disease. The patient was discharged home with appropriate follow-up care instructions.	
Which coreferential expressions were resolved in the hospital course section of the provided discharge summary related to the patient's medical history of Langerhans cell histiocytosis?	
In the hospital course section of the discharge summary, coreferential expressions related to the patient's medical history of Langerhans cell histiocytosis that were resolved include "it" and "the lesions".	
Coreference Resolution
16	
Discharge Summary: Patient Name: [redacted] Date of Discharge: [redacted] Admission Date: [redacted] Admission Diagnosis: Obstructing ureteral stone with resultant bilateral hydronephrosis, severe anion gap metabolic acidosis, acute renal failure Hospital Course: The patient is a 55-year-old male with a history of hypertension and type 2 diabetes mellitus who presented with sudden onset shortness of breath and three days of non-radiating lumbar back pain. Upon initial examination, the patient had significant work of breathing and abdominal breathing, with significant concern for acute coronary syndrome, dissection, sepsis, or pulmonary embolism. Blood work and CT-angiogram were ordered, revealing an obstructing stone at the left proximal ureteropelvic junction and at the right ureterovesical junction, with resultant bilateral hydronephrosis. The patient was provided with broad-spectrum antibiotics, Vancomycin and Cefepime, and aggressive fluid resuscitation was initiated. Due to the expected clinical decline, he was intubated in the emergency department. After initial stabilization, bilateral percutaneous nephrostomy (PCN) was placed, and a trialysis catheter was inserted to initiate hemodialysis. Upon transfer to the ICU, the patient was maintained on multiple vasopressors, consisting of combinations of norepinephrine, vasopressin, epinephrine, and phenylephrine. Continuous renal replacement therapy (CRRT) was initiated due to worsening metabolic and lactic acidosis, with the patient’s pH stabilizing and blood pressure normalizing within 24 hours. The patient was successfully weaned off all vasopressors, and CRRT was stopped on hospital day 3. On hospital day 6, Urology performed a cystoscopy with bilateral ureteral stent placement and removal of bilateral percutaneous nephrostomy tubes. Discharge Medications: The patient was discharged on the following medications: [missing from the original report] Post-Discharge Instructions: The patient was instructed to follow up with Urology in 1-2 weeks. Discharge Condition: Upon discharge, the patient’s creatinine was 1.5, BUN 27, indicating recovering renal function, and he made a remarkable recovery from being critically ill. Follow-Up Appointment: The patient was instructed to follow up with Urology in 1-2 weeks.	
Which coreferents were resolved in the discharge summary related to the patient's diagnosis and treatment?	
The patient's obstructing ureteral stone with bilateral hydronephrosis was treated with bilateral percutaneous nephrostomy followed by bilateral ureteral stent placement. The patient's renal function has started to recover, and they were advised to follow up with Urology in 1-2 weeks. However, the discharge medications were missing from the original report, so we cannot provide that information.	
Coreference Resolution
17	
Discharge Summary Patient Name: [redacted] Medical Record Number: [redacted] Admission Date: [redacted] Discharge Date: [redacted] Diagnosis: Anti-proteinase 3 (anti-PR3)-associated ANCA glomerulonephritis Clinical Course: The patient, a 58-year-old Caucasian male, presented with nausea, vomiting, and 30-pound weight loss over the past two months. He reported dark-colored urine and intermittent episodes of hemoptysis after receiving his second dose of the mRNA-1273 (Moderna) vaccine for COVID-19. Laboratory analysis revealed serum creatinine of 4.1 mg/dL, hematuria, and sub-nephrotic proteinuria. A computed tomography (CT) scan of the chest showed right upper lobe consolidation and moderate bilateral pleural effusion. Renal biopsy confirmed acute, pauci immune, focal necrotizing, and diffuse crescentic glomerulonephritis. The patient was diagnosed with anti-PR3-associated ANCA glomerulonephritis and received intensive immunosuppression treatment with plasma exchange x 5 cycles, intravenous prednisone 1 gram x 3 doses followed by prednisone 60 mg daily, cyclophosphamide x 2 doses, and rituximab x 4 doses. The patient achieved remission after 10 weeks of diagnosis with a resolution of symptoms and improvement in renal function. Admission Diagnosis: N/A Discharge Diagnosis: Anti-PR3-associated ANCA glomerulonephritis Hospital Course: The patient reported symptoms of nausea, vomiting, and 30-pound weight loss over the past two months after receiving the mRNA-1273 (Moderna) vaccine for COVID-19. Laboratory analysis revealed elevated serum creatinine, hematuria, and sub-nephrotic proteinuria. A CT scan of the chest showed right upper lobe consolidation and moderate bilateral pleural effusion. Renal biopsy confirmed acute, pauci immune, focal necrotizing, and diffuse crescentic glomerulonephritis. The patient was treated with intensive immunosuppression therapy and achieved remission after 10 weeks of diagnosis with a resolution of symptoms and improvement in renal function. Patient was discharged in stable condition and is following up with the nephrology office regularly. Medications: N/A Allergies: N/A Follow-up: Patient is following up with the nephrology office regularly.	
What clinical Named Entities related to the patient's condition, anatomical findings, and treatments can be extracted using Named Entity Recognition from this discharge summary?	
Using Named Entity Recognition, we can extract the following clinical Named Entities related to the patient's condition, anatomical findings, and treatments: - Diagnosis: Anti-proteinase 3 (anti-PR3)-associated ANCA glomerulonephritis - Clinical findings: nausea, vomiting, weight loss, dark-colored urine, hemoptysis, serum creatinine, hematuria, sub-nephrotic proteinuria, right upper lobe consolidation, moderate bilateral pleural effusion, acute, pauci immune, focal necrotizing, and diffuse crescentic glomerulonephritis - Treatments: plasma exchange, prednisone, cyclophosphamide, and rituximab. It should be noted that there were no medications or allergies mentioned in the discharge summary. The admission diagnosis was not provided.	
Named Entity Recognition
18	
Discharge Summary: Hospital Course: The 67-year-old Caucasian female was admitted to the hospital with a chief complaint of persistent bright red blood per rectum. The patient had a significant medical history of hypertension, high cholesterol, Type-2 diabetes mellitus, coronary artery disease, recurrent cerebrovascular accidents, gastroesophageal reflux disease, asthma, and endometrial cancer status post radiation therapy. The patient underwent total abdominal hysterectomy with bilateral salpingo-oopherectomy after being diagnosed with grade 1 endometrial adenoma 15 months prior to current presentation. The patient had no prior history of gastrointestinal bleeding. Admission Findings: Physical examination revealed mild left-sided abdominal tenderness but was otherwise unremarkable. Rectal examination revealed nonbleeding hemorrhoids. Blood work showed an elevated white blood cell count and low hemoglobin. Creatinine and blood urea nitrogen were slightly elevated as well. A colonoscopy revealed a large, fungating, friable, and ulcerated nonobstructing mass in the sigmoid colon. Biopsies were obtained with cold forceps for histology and tattooed margins. Histology showed invasive and moderately differentiated carcinoma without visible goblet cells indicating an endometrial primary. Treatment and Discharge: The patient underwent surgical resection of the affected colon followed by radiation therapy. The tumor marker carcinoembryonic antigen level was normal, and pan-computed tomography was negative for any obvious distant disease. One year post-surgery, the patient is doing well without any active GI complaints and is discharged. Appropriate home care instructions were given to the patient upon discharge. Follow-up: The patient is advised to have regular follow-up appointments with their primary care physician and gastroenterologist to keep a close watch for any possible recurrences. The patient is instructed to follow-up with their oncologist for further treatment recommendations. The patient was provided with a copy of these discharge instructions before leaving the hospital.	
What named entities related to the patient's cancer diagnosis can be identified through Named Entity Recognition in this discharge summary?	
Using Named Entity Recognition on the given discharge summary, the identified named entities related to the patient's cancer diagnosis include endometrial cancer, grade 1 endometrial adenoma, invasive and moderately differentiated carcinoma, and tumor marker carcinoembryonic antigen level.	
Named Entity Recognition
20	
Hospital Course: The patient is a 78-year-old male with a history of cutaneous T-cell lymphoma/mycosis fungoides, type II diabetes mellitus, atrial flutter, and sick sinus syndrome who presented to the hospital with right upper quadrant abdominal pain. Laboratory evaluation revealed abnormal liver function tests with elevated AST/ALT and ALP levels and a total bilirubin level of 2.5 mg/dL. Imaging studies, including ultrasound of the abdomen, CT abdomen and pelvis, CT angiography of the chest, and HIDA scan were negative for acute pathology. Given the patient's medical history, the differential diagnosis included leukemic infiltration of the liver or adverse reaction to prior chemotherapy. A percutaneous liver biopsy was performed, and the results showed high-grade tumor cells with positive immunohistochemical staining for cytokeratin AE1/AE3, CK20, synaptophysin, and chromogranin, and negative for CK7, CDX-2, and TTF-1. These findings were consistent with metastatic Merkel cell carcinoma. The patient and family opted for comfort care measures given the medical comorbidities and were discharged home with consultation with Hematology/Oncology and Dermatology. Follow-up with primary care physician and palliative care team was recommended.	
What are the key findings and diagnosis of the patient with cutaneous T-cell lymphoma/mycosis fungoides, type II diabetes mellitus, atrial flutter, sick sinus syndrome, and metastatic Merkel cell carcinoma in the given discharge summary?	
The key findings of the patient include abnormal liver function tests with elevated AST/ALT and ALP levels and a total bilirubin level of 2.5 mg/dL, which were later consistent with metastatic Merkel cell carcinoma after a percutaneous liver biopsy. The patient's medical history includes cutaneous T-cell lymphoma/mycosis fungoides, type II diabetes mellitus, atrial flutter, and sick sinus syndrome. The patient and family opted for comfort care measures due to medical comorbidities, and follow-up with the primary care physician and palliative care team was recommended.	
Summarization
21	
Discharge Summary: Hospital Course: The patient is a 24-year-old woman who presented with difficulty breathing and dissatisfaction with her facial appearance. She had a history of childhood trauma resulting in nasal septum deviation and external nasal deformity. Four months after a successful septorhinoplasty, she presented to the emergency department with blunt nasal trauma resulting in a septal hematoma, which was drained successfully; the patient was discharged with no adverse sequelae. Four months later, the patient sustained nasal trauma again, resulting in clear nasal discharge, raising suspicion of cerebrospinal fluid (CSF) leak. The patient was discharged from the hospital after managing the nasal injury, as the CT brain showed an intact cribriform plate with no evidence of a CSF leak. Ten days later, she presented at the emergency department with dizziness and an unstable gait. Findings: The patient presented with additional symptoms such as paresthesia, starting in her right hand and progressing to the right shoulder, arm, and leg, and some difficulty in executing movements in the first and second finger of her right hand. She also had stiffness in her right leg and difficulty walking. On close inquiry, she gave a history of pain in the right eye and double vision many months earlier, which had resolved spontaneously. Examination showed a positive Romberg’s and Lhermitte’s sign, with right-sided sensory impairment. Diagnosis And Treatment: MRI of the brain, cervical, and thoracic spine demonstrated demyelinating lesions in the brain and cervical segment of the spinal cord. Some of the lesions showed enhancement on post gadolinium administration sequences, suggestive of active demyelinating diseases like MS. A lumbar puncture was performed revealing the presence of oligoclonal bands in the CSF. The diagnosis of MS was confirmed by a neurologist, and treatment was initiated. Outcome: The initial neurological symptoms have largely vanished, with only persistent light paresthesia in the right hand. Two years later, the patient has had no new symptoms and continues with the same medication, with good tolerance. The patient was discharged in stable condition with instructions to follow-up with the neurologist for management and monitoring of her MS condition.	
What is the expanded form of the abbreviation 'CSF'?	
The expanded form of the abbreviation 'CSF' is cerebrospinal fluid. This is a clear, colorless liquid that bathes the brain and spinal cord. It provides cushioning and nutrients to these structures.	
Abbreviation Expansion
22	
Discharge Summary: Patient Information: Name: [Redacted] Age: 64 years old Sex: Male Date of admission: Unknown Date of discharge: Unknown Admitting physician: Unknown Attending physician: Unknown Diagnosis: UC of the renal pelvis with sarcomatoid differentiation (70%) and unusual histological differentiation including squamous (25%), and glandular (<5%) Hospital Course: The patient presented to King Abdulaziz Medical City with complaints of gross hematuria, abdominal and left colicky flank pain for six months. Lab results showed isolated S. aureus and urinalysis revealed small blood quantity with moderate leukocytes and trace protein. CT, bone scan, and chest CT were performed, which did not show any significant abnormality or metastasis. The patient underwent ureteroscopy with cytology and culture based on his MRI findings. Urine culture was positive for S. aureus, and the patient was given an appointment for left nephroureterectomy which was performed successfully. A cystourethrogram was performed, and there was no leak. The patient was planned to receive adjuvant chemotherapy and PET-CT for doubtful distant lymphadenopathy. The patient missed the scheduled appointment, and the current status of the patient is unknown. Procedure: 1) CT of the abdomen and pelvis 2) Magnetic resonance imaging (MRI) 3) Ureteroscopy with cytology and culture 4) Open left radical nephroureterectomy 5) Cystourethrogram Medical Condition: The patient had been diagnosed with UC of the renal pelvis with sarcomatoid differentiation (70%) and unusual histological differentiation including squamous (25%), and glandular (<5%) Discharge instructions: Patient missed scheduled appointments.	
What was the reason for the patient missing the scheduled appointment for adjuvant chemotherapy and PET-CT? (Related to the task of Relation Extraction)	
The discharge summary does not provide information on the reason for the patient missing the scheduled appointment for adjuvant chemotherapy and PET-CT.	
Relation Extraction
23	
Discharge Summary: Patient with a history of aortic valve replacement, Factor V Leiden anomaly, and migraines presented with new paracentral blind spots in the right eye. Spectral-domain OCT imaging revealed hyperreflective bands in the middle retina, consistent with PAMM. Niacinamide, aspirin, and ibuprofen were administered for relief of left-sided visual scotoma without success. Nitroglycerin was found to be effective in treating subsequent episodes of visual scotomas. The patient describes the lesions as small opaque structures obstructing the field of vision with a purple hue. Consultations with the Chief of the Retinal Service at the New York Eye and Ear Infirmary confirm the diagnosis of PAMM. No treatment was given at the time of initial diagnosis. The patient experiences symptoms primarily following episodes of extreme physical activity. In summary, the patient is clinically diagnosed with PAMM and has been successfully treated with nitroglycerin for episodes of visual scotomas. Follow-up with ophthalmologist recommended.	
Which Named Entities related to the diagnosis and treatment of paracentral acute middle maculopathy (PAMM) can be recognized through Named Entity Recognition in this discharge summary?	
The Named Entities related to the diagnosis and treatment of paracentral acute middle maculopathy (PAMM) that can be recognized through Named Entity Recognition in this discharge summary are: aortic valve replacement, Factor V Leiden anomaly, migraines, Spectral-domain OCT imaging, hyperreflective bands in the middle retina, niacinamide, aspirin, ibuprofen, nitroglycerin, lesions, purple hue, and ophthalmologist. However, it should be noted that no specific treatment was given for PAMM at the time of initial diagnosis.	
Named Entity Recognition
24	
Hospital Course: The patient, a 68-year-old female with a history of G3P2 pregnancy and a pancreatoduodenectomy to remove a duodenal papillae adenocarcinoma, was admitted to the hospital for suspicion of an ovarian tumor. Upon examination, a mass with abundant internal blood flow in the bladder mucosa was discovered. The patient was referred to the Department of Urology. Investigations: Urinalysis revealed no hematuria, but urine cytology showed dysmorphic cells indicative of a tumor. Cystoscopy revealed a stalked papillary tumor at the apex of the posterior wall of the bladder. Diagnosis: Transurethral resection of bladder tumor was performed to remove the 2-cm papillary tumor. The pathology report confirmed that the mass was a non-muscle-invasive bladder tumor (transitional cell carcinoma, stage 0a). The patient was administered intravesical chemotherapy. Outcome: At the three-month postoperative follow-up, no recurrence was observed. Postoperative CT examination has not yet been conducted. The patient was discharged in stable condition. Summary: The patient presented with a suspected ovarian tumor but was found to have a bladder tumor. The bladder tumor was resected, and the pathology report revealed a transitional cell carcinoma. The patient received intravesical chemotherapy and had no recurrence at the three-month postoperative follow-up. The patient was discharged in stable condition.	
What coreferents needed to be resolved in the diagnosis and treatment of the patient's bladder tumor in the given discharge summary?	
The coreferents that needed to be resolved in the diagnosis and treatment of the patient's bladder tumor were the identification of the tumor as a non-muscle-invasive bladder tumor and the administration of intravesical chemotherapy. However, the discharge summary did not provide information on whether the patient has received any other treatment or if a postoperative CT examination was scheduled, making it unanswerable if such coreferents were resolved or not.	
Coreference Resolution
25	
Discharge Summary: Admitting Diagnosis: COVID-19 Pneumonia Hospital Course: The patient was admitted with symptoms of shortness of breath, cough, myalgias, nausea, vomiting, diarrhea, and fevers. The initial evaluation showed a positive nasopharyngeal swab for SARS-CoV-2, bilateral pneumonia seen on CT chest with contrast, and elevated levels of D-dimer, INR, NT-proBNP, and troponin. The patient was started on ceftriaxone, azithromycin, dexamethasone, and remdesivir. During the hospitalization, the patient's EKG showed sinus tachycardia and left axis deviation on admission, followed by sinus bradycardia with nonspecific intraventricular conduction delay after three days of remdesivir. On the third day after discontinuing remdesivir, the patient had a transient arrhythmia. Potassium levels were low initially and normalized after repletion on day two of hospital stay. Magnesium levels were normal throughout the hospital stay. The patient responded well to treatment and improving symptoms were noted during the hospitalization. Final Diagnosis: COVID-19 Pneumonia Disposition and Condition at Discharge: The patient was discharged home in stable condition with instructions to follow up with their primary care physician. The patient was advised to continue the recommended COVID-19 precautions including mask-wearing, hand hygiene, and social distancing. The patient was also advised to follow up with their healthcare provider in case of any worsening symptoms or concerns related to COVID-19. Follow-Up Care: Follow-up care was advised with the primary care physician to continue monitoring the patient's COVID-19 symptoms and overall recovery.	
What relation can be extracted regarding the patient's arrhythmia and the medication 'Remdesivir' used during the hospital stay for COVID-19 pneumonia?	
The patient experienced a transient arrhythmia three days after starting Remdesivir and had sinus bradycardia with nonspecific intraventricular conduction delay after three days of Remdesivir. However, there is no clear evidence from the given information that directly links the arrhythmia to the use of Remdesivir. It is possible that the arrhythmia was due to the patient's underlying condition, COVID-19 pneumonia, or other factors. Further evaluation and monitoring may be necessary to determine the cause of the arrhythmia.	
Relation Extraction
26	
Discharge Summary: Patient Name: [redacted] Age: 54 years Gender: Female Race/Ethnicity: Hispanic Hospital Course: The patient was admitted to the hospital with symptoms of COVID-19, including shortness of breath, cough, and chest pain. Lab work showed positive for SARS-CoV-2, and chest x-ray showed bilateral lung opacities. The patient was started on ceftriaxone, azithromycin, and dexamethasone and later on remdesivir. However, after two doses of remdesivir, the patient developed severe sinus bradycardia with a persistent HR of 45-60 bpm throughout the hospitalization. Clinical Impression: The patient's clinical impression includes COVID-19 infection with pulmonary infiltrates, leukopenia, elevated D-dimer, hyperglycemia, elevated liver enzymes, elevated c-reactive protein, and elevated respiratory procalcitonin. Hospital Course: The patient was admitted to the telemetry unit and evaluated upon initial presentation. Hospitalization included treatment with ceftriaxone, azithromycin, and dexamethasone, followed by remdesivir. After two doses of remdesivir, the patient developed severe sinus bradycardia with HR of 30-40 bpm, and the medication was discontinued. Diagnostic Results: Lab work showed nasopharyngeal swab positive for SARS-CoV-2, leukopenia (WBC: 3.8x103/uL), elevated D-dimer (514 ng/mL), hyperglycemia (126 mg/dL), elevated liver enzymes (AST: 224 U/L, ALT: 175 U/L), elevated c-reactive protein (CRP) (129.8 mg/L), and elevated respiratory procalcitonin (0.26 ng/mL). Chest x-ray showed bilateral lung opacities, and CT chest with contrast showed moderate bilateral pulmonary infiltrates. Discharge Instructions: The patient was discharged after receiving appropriate COVID-19 treatment, management of the sinus bradycardia, and hemodynamic stability. The patient should continue to monitor and manage her diabetes and follow up with her primary care provider.	
What is the relationship between the patient's administration of remdesivir and the development of severe sinus bradycardia with a persistent HR of 45-60 bpm throughout hospitalization?	
The patient's administration of remdesivir was related to the development of severe sinus bradycardia with a persistent HR of 45-60 bpm throughout hospitalization. After two doses of remdesivir, the medication was discontinued, and appropriate treatment was given to manage the bradycardia and maintain hemodynamic stability.	
Relation Extraction
27	
Discharge Summary Patient Name: [redacted] Gender: Female Age: 59 Medical Record Number: [redacted] Date of Admission: [redacted] Date of Discharge: [redacted] Hospital Course: The patient was admitted due to lower back pain associated with weakness of lower extremities, numbness, tingling, and balance issues. She also had constipation and urinary incontinence. A workup was initiated for an occult malignancy due to diffuse osteosclerotic lesions in visualized bones. CT scan of the chest revealed no pulmonary lesions but several subcutaneous lesions on the back. MRI of the brain and spine showed abnormal leptomeningeal enhancement in the brainstem extending along the entire spinal cord. Lumbar puncture showed increased protein and white blood cells in cerebrospinal fluid. Peripheral blood flow cytometry revealed monoclonal B cell lymphocytosis. Finally, a right iliac bone biopsy was done that revealed metastatic adenocarcinoma of the breast. Treatment: The patient was started on letrozole initially with dexamethasone taper, followed by palliative radiation therapy with 30 Gy in 10 fractions to the lumbosacral spine which improved her lower back pain. After completion of the radiation therapy, abemaciclib was added to letrozole as the systemic therapy and she showed excellent response to the treatment. She does continue to have sclerotic changes in her bones; however, she deferred from bone-targeted therapy. Follow-up: The patient has been on abemaciclib and letrozole for about two years, her neurological symptoms have improved, and now she has a good quality of life. She is able to walk half a mile on flat ground and is able to perform light household chores. Follow-up scans showed no leptomeningeal enhancements; however, she does continue to have sclerotic changes in her bones.	
What is the relationship between the detected monoclonal B cell lymphocytosis and the metastatic adenocarcinoma detected in the right iliac bone biopsy according to the discharge summary using relation extraction?	
According to the discharge summary, the monoclonal B cell lymphocytosis was detected through peripheral blood flow cytometry. The right iliac bone biopsy revealed metastatic adenocarcinoma of the breast. There is no direct specified relationship between the two conditions in the discharge summary. However, monoclonal B cell lymphocytosis may be a manifestation of an underlying hematologic malignancy, which in this case was metastatic breast adenocarcinoma.	
Relation Extraction
28	
Discharge Summary Patient Name: [REDACTED] MRN: [REDACTED] DOB: [REDACTED] Admission Date: [REDACTED] Discharge Date: [REDACTED] Clinical Summary: The patient is a 33-year-old female with no known comorbidities who recently gave birth to a healthy girl child. She was brought to the emergency department with sudden onset weakness of both upper and lower limbs, which progressed rapidly to quadriplegia. She had bilateral facial palsy and bulbar palsy. She was diagnosed with central pontine myelinolysis (CPM) due to idiopathic hypernatremic osmotic demyelination. The patient was treated with sodium correction and pulse methylprednisolone and discharged with a modified Rankin Scale score (mRS) of 0. One year later, the patient presented to the neurology department with generalized fatigue, diffuse myalgias, and rapidly progressive weakness of all four limbs, which made her wheelchair-bound one day before the presentation. Clinical examination revealed pure motor flaccid symmetric quadriparesis with proximal more than distal weakness and generalized hyporeflexia. Nerve conduction studies showed reduced compound muscle action potential (CMAP) amplitudes of bilateral tibial and peroneal nerves with absent F waves and H reflexes. The patient was diagnosed with Guillain-Barré syndrome (GBS) or hypokalemia-related electrophysiological abnormalities. Basic metabolic panel revealed severe hypokalemia, and arterial blood gas (ABG) and 24-hour urine analysis showed metabolic acidosis, consistent with renal tubular acidosis type-1 (distal). Autoimmune workup was positive for anti-SSA/Ro autoantibodies, and minor salivary gland biopsy was pathognomonic. The patient was diagnosed with primary Sjogren's syndrome (pSS) according to the new classification criteria proposed by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). Hospital Course: The patient was given intravenous (IV) potassium supplementation and subsequently shifted to oral liquid formulation. Oral sodium bicarbonate supplementation was given for renal tubular acidosis. With potassium correction, there was a rapid recovery in the power of all four limbs within 24 hours of admission. The patient was initiated on oral prednisolone and referred to a rheumatologist for further management. She remained asymptomatic on her six-month follow-up. Discharge Medications: N/A Follow-Up Appointments: The patient was referred to a rheumatologist for further management. Instructions: The patient should follow-up with her rheumatologist. The patient should continue taking oral potassium and sodium bicarbonate as prescribed. The patient should maintain proper hydration and electrolyte balance. Discharge Diagnosis: 1. Central pontine myelinolysis (CPM) due to idiopathic hypernatremic osmotic demyelination 2. Primary Sjogren's syndrome (pSS) with renal tubular acidosis and hypokalemia-related quadriparesis due to hypokalemia Disposition: The patient was discharged in stable condition.	
Could you rephrase the medical terminology used in this discharge summary to make it more accessible for a patient and their family, specifically in regards to the patient's diagnosis of primary Sjogren's syndrome and its related conditions?	
Certainly. Primary Sjogren's syndrome is an autoimmune condition that affects the glands that make saliva and tears. In this case, it caused renal tubular acidosis (a kidney problem that causes an imbalance of acid in the body) and hypokalemia (low potassium levels), which led to weakness in all four limbs. The patient received treatment for their potassium deficiency and acidosis, as well as medication to manage their autoimmune condition. They will need to follow up with their rheumatologist and continue taking their prescribed medication to maintain proper electrolyte balance and manage their condition.	
Paraphrasing
29	
Discharge Summary: Patient Name: [REDACTED] DOB: [REDACTED] Sex: Female Admission Date: [REDACTED] Discharge Date: [REDACTED] Reason for Admission: The patient was admitted with shortness of breath, cough, myalgias, and malaise in the setting of a positive SARS-CoV-2 test result. Hospital Course: Upon admission, the patient was started on supplemental oxygen, remdesivir, dexamethasone, furosemide, azithromycin, and enoxaparin for venous thromboembolism prophylaxis. The patient's clinical course was challenging, despite multiple measures, and required more aggressive management. Repeat chest X-ray showed slight interval improvement of bilateral pulmonary infiltrates. The patient's condition gradually improved over the course of her hospital stay, and she was eventually determined to be fit for discharge. Discharge Medications: Patient's discharge medications will be managed by her primary care provider (PCP). Follow-Up: The patient should follow up with her PCP within seven days and continue to monitor her symptoms. Summary: The patient was admitted due to shortness of breath, cough, myalgias, and malaise in the setting of a positive SARS-CoV-2 test result. Despite multiple measures, the patient's clinical course was challenging and required more aggressive management. The patient's clinical condition gradually improved, and she was eventually discharged. The patient will follow up with her PCP within seven days and continue to monitor her symptoms.	
What medications were administered to the patient during their hospital stay for the treatment of shortness of breath, cough, myalgias, and malaise, as mentioned in the discharge summary?	
The patient was administered remdesivir, dexamethasone, furosemide, azithromycin, and enoxaparin for venous thromboembolism prophylaxis during her hospital stay for the treatment of shortness of breath, cough, myalgias, and malaise, as mentioned in the discharge summary.	
Question Answering
30	
Discharge Summary: Patient Name: [Patient's name] Medical Record Number: [Patient's medical record number] Date of Admission: [Date of admission] Date of Discharge: [Date of discharge] Hospital Course: The patient was admitted to the hospital due to shortness of breath, fever, and cough for three days, and was diagnosed with COVID-19. The patient had received two doses of the COVID vaccine before admission. Upon admission, the patient's vital signs were within normal limits, but the patient was febrile with a temperature of 102.0°F. Laboratory assessment results were abnormal, with details provided in the patient's medical record. The patient was started on antibiotics, dexamethasone, and remdesivir. CT chest on admission showed nonspecific nodules, and no acute infiltrates were observed. However, on Day 2, the patient's hypoxia worsened, and CT chest showed severe bilateral airspace disease throughout the lungs. The patient required supplemental oxygen via nasal cannula. The patient's clinical status improved during hospitalization with appropriate interventions and supportive care. The patient's oxygen requirements decreased, and the patient was able to be weaned off supplemental oxygen. The patient's clinical condition was monitored regularly during hospitalization, and the patient's vital signs remained stable within normal limits. Discharge Instructions: The patient was discharged from the hospital with instructions to continue practicing COVID-safe behaviors, including wearing a mask, washing hands frequently, and practicing social distancing. The patient was advised to contact the hospital immediately if the symptoms returned or worsened. Follow-up: The patient was advised to schedule a follow-up appointment with their primary care provider to ensure proper monitoring of their recovery and receive any necessary further medical intervention. Signed, [Physician Name]	
How can you rephrase the patient's hospital course and condition during admission and discharge from COVID-19 to ensure it is more readily understandable by non-medical professionals?	
The patient was admitted to the hospital due to symptoms of COVID-19 and was treated with antibiotics, dexamethasone, and remdesivir. The patient's condition improved during hospitalization and was discharged with instructions to continue COVID-safe behaviors and seek medical attention if symptoms return or worsen. A follow-up appointment with a primary care provider was recommended for proper monitoring and additional medical care if needed.	
Paraphrasing